154 related articles for article (PubMed ID: 6775643)
1. Use of etidronate (EHDP) in Paget's disease of bone.
Johnston CC; Khairi MR; Meunier PJ
Arthritis Rheum; 1980 Oct; 23(10):1172-6. PubMed ID: 6775643
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
[TBL] [Abstract][Full Text] [Related]
3. Long-term therapy of Paget's disease of bone with EHDP.
Siris ES; Canfield RE; Jacobs TP; Baquiran DC
Arthritis Rheum; 1980 Oct; 23(10):1177-84. PubMed ID: 6775644
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
[TBL] [Abstract][Full Text] [Related]
5. Diphosphonate therapy of paget's disease of bone.
Canfield R; Rosner W; Skinner J; McWhorter J; Resnick L; Feldman F; Kammerman S; Ryan K; Kunigonis M; Bohne W
J Clin Endocrinol Metab; 1977 Jan; 44(1):96-106. PubMed ID: 401827
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone.
Altman RD
Am J Med; 1985 Nov; 79(5):583-90. PubMed ID: 3933343
[TBL] [Abstract][Full Text] [Related]
7. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
Khairi MR; Altman RD; DeRosa GP; Zimmermann J; Schenk RK; Johnston CC
Ann Intern Med; 1977 Dec; 87(6):656-63. PubMed ID: 412450
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
Rashid M; Khairi A; Johnston C
Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
[No Abstract] [Full Text] [Related]
9. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).
Johnston CC; Altman RD; Canfield RE; Finerman GA; Taulbee JD; Ebert ML
Clin Orthop Relat Res; 1983; (172):186-94. PubMed ID: 6401608
[No Abstract] [Full Text] [Related]
10. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
[TBL] [Abstract][Full Text] [Related]
11. Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
O'Donoghue DJ; Hosking DJ
Bone; 1987; 8(4):219-25. PubMed ID: 3128315
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
Stein I; Shapiro B; Ostrum B; Beller ML
Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.
Miller PD; Brown JP; Siris ES; Hoseyni MS; Axelrod DW; Bekker PJ
Am J Med; 1999 May; 106(5):513-20. PubMed ID: 10335722
[TBL] [Abstract][Full Text] [Related]
15. [Non-hormonal drug treatment in Paget's disease].
Ryckewaert A; Lemaire V; Tubiana M
Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):693-8. PubMed ID: 131365
[TBL] [Abstract][Full Text] [Related]
16. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
Roux C; Gennari C; Farrerons J; Devogelaer JP; Mulder H; Kruse HP; Picot C; Titeux L; Reginster JY; Dougados M
Arthritis Rheum; 1995 Jun; 38(6):851-8. PubMed ID: 7779130
[TBL] [Abstract][Full Text] [Related]
17. Effective short term treatment of Paget's disease with oral etidronate.
Preston CJ; Yates AJ; Beneton MN; Russell RG; Gray RE; Smith R; Kanis JA
Br Med J (Clin Res Ed); 1986 Jan; 292(6513):79-80. PubMed ID: 3080099
[TBL] [Abstract][Full Text] [Related]
18. The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
Ralston SH; Boyce BF; Cowan RA; Fogelman I; Smith ML; Jenkins A; Boyle IT
J Bone Miner Res; 1987 Feb; 2(1):5-12. PubMed ID: 3137773
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
Alexandre CM; Chapuy MC; Vignon E; Edouard C; Johnston CC; Meunier PJ
Clin Orthop Relat Res; 1983 Apr; (174):193-205. PubMed ID: 6403270
[TBL] [Abstract][Full Text] [Related]
20. A patient with Paget's disease of bone treated with etidronate disodium.
Koga K; Kawasaki K; Kohno S; Yamada K; Itoh T; Nonaka K
Kurume Med J; 1998; 45(4):345-9. PubMed ID: 9914722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]